Related references
Note: Only part of the references are listed.SPARC production by bone marrow-derived cells contributes to myocardial fibrosis in pressure overload
Hannah J. Riley et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2021)
Secreted Protein Acidic and Cysteine Rich Matricellular Protein Is Enriched in the Bioactive Fraction of the Human Vascular Pericyte Secretome
Elisa Avolio et al.
ANTIOXIDANTS & REDOX SIGNALING (2021)
Deficiency of tenascin-C attenuated cardiac injury by inactivating TLR4/ NLRP3/caspase-1 pathway after myocardial infarction
Mingyue Xu et al.
CELLULAR SIGNALLING (2021)
Bearing My Heart: The Role of Extracellular Matrix on Cardiac Development, Homeostasis, and Injury Response
Ana Catarina Silva et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)
Generation of Transgenic Mice that Conditionally Overexpress Tenascin-C
Saori Yonebayashi et al.
FRONTIERS IN IMMUNOLOGY (2021)
Direct in vivo reprogramming with non-viral sequential targeting nanoparticles promotes cardiac regeneration
Qiaozi Wang et al.
BIOMATERIALS (2021)
Evaluation of the serum levels of Mannose binding lectin-2, tenascin-C, and total antioxidant capacity in patients with coronary artery disease
Hamed Mehri et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2021)
Prognostic Value of Cysteine-Rich Protein 61 Combined with N-Terminal Pro-B-Type Natriuretic Peptide for Mortality in Acute Heart Failure Patients with and without Chronic Kidney Disease
Chen Liu et al.
CARDIORENAL MEDICINE (2020)
Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohort
Barnabas Gellen et al.
DIABETOLOGIA (2020)
Serum tenascin-C levels in atrium predict atrial structural remodeling processes in patients with atrial fibrillation
Yuichiro Shiomi et al.
JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY (2020)
Osteopontin as novel biomarker for reversibility of pressure overload induced left ventricular hypertrophy
Andreas Weber et al.
BIOMARKERS IN MEDICINE (2020)
Syndecan-4 Protects the Heart From the Profibrotic Effects of Thrombin-Cleaved Osteopontin
Kate M. Herum et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Plasma Tenascin-C: a prognostic biomarker in heart failure with preserved ejection fraction
Prathap Kanagala et al.
BIOMARKERS (2020)
A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection From Myocardial Infarction
Ni Xia et al.
CIRCULATION (2020)
Cardiac fibrosis - A short review of causes and therapeutic strategies
Svenja Hinderer et al.
ADVANCED DRUG DELIVERY REVIEWS (2019)
CCN1-Induced Cellular Senescence Promotes Heart Regeneration
Teng Feng et al.
CIRCULATION (2019)
Impaired bone matrix glycoprotein pattern is associated with increased cardio-metabolic risk profile in patients with type 2 diabetes mellitus
I Barchetta et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2019)
Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization
Taizo Kimura et al.
CARDIOVASCULAR RESEARCH (2019)
Thrombospondin-3 augments injury-induced cardiomyopathy by intracellular integrin inhibition and sarcolemmal instability
Tobias G. Schips et al.
NATURE COMMUNICATIONS (2019)
Syndecan-1 Predicts Outcome in Patients with ST-Segment Elevation Infarction Independent from Infarct-related Myocardial Injury
Bernhard Wernly et al.
SCIENTIFIC REPORTS (2019)
Periostin function in communication with extracellular matrices
Akira Kudo et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Increased macrophage-derived SPARC precedes collagen deposition in myocardial fibrosis
Lindsay T. McDonald et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2018)
Thrombospondin-4 mediates cardiovascular remodelling in angiotensin ll-induced hypertension
Teresa Palao et al.
CARDIOVASCULAR PATHOLOGY (2018)
IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction
Kohsuke Shirakawa et al.
CIRCULATION (2018)
Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis
Bruno K. Podesser et al.
JOURNAL OF HYPERTENSION (2018)
SPARC preserves endothelial glycocalyx integrity, and protects against adverse cardiac inflammation and injury during viral myocarditis
Marieke Rienks et al.
MATRIX BIOLOGY (2018)
Prognostic Significance of Serum Cysteine-Rich Protein 61 in Patients with Acute Heart Failure
Jingjing Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Presence of increased inflammatory infiltrates accompanied by activated dendritic cells in the left atrium in rheumatic heart disease
Mikio Shiba et al.
PLOS ONE (2018)
TSP1-CD47 signaling is upregulated in clinical pulmonary hypertension and contributes to pulmonary arterial vasculopathy and dysfunction
Natasha M. Rogers et al.
CARDIOVASCULAR RESEARCH (2017)
Cysteine-rich 61 (Cyr61) upregulated in pulmonary arterial hypertension promotes the proliferation of pulmonary artery smooth muscle cells
Lan Gao et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
Bone Marrow-Derived Tenascin-C Attenuates Cardiac Hypertrophy by Controlling Inflammation
Lei Song et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats
Keisuke Imoto et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2017)
Introductory review: periostin-gene and protein structure
Akira Kudo
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Osteopontin RNA aptamer can prevent and reverse pressure overload-induced heart failure
Jihe Li et al.
CARDIOVASCULAR RESEARCH (2017)
Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile
I. Barchetta et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2016)
Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy
Tetsuro Yokokawa et al.
EUROPEAN JOURNAL OF HEART FAILURE (2016)
Nuclear matrix metalloproteinase-2 in the cardiomyocyte and the ischemic-reperfused heart
Sabina Baghirova et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction
Yuichi Kimura et al.
HEART AND VESSELS (2016)
The role of circulating thrombospondin-1 in patients with precapillary pulmonary hypertension
Ralf Kaiser et al.
RESPIRATORY RESEARCH (2016)
Combined Intramyocardial Delivery of Human Pericytes and Cardiac Stem Cells Additively Improves the Healing of Mouse Infarcted Hearts Through Stimulation of Vascular and Muscular Repair
Elisa Avolio et al.
CIRCULATION RESEARCH (2015)
Tenascin-C May Accelerate Cardiac Fibrosis by Activating Macrophages via the Integrin αVβ3/NuclearFactor-κB/Interleukin-6 Axis
Naoshi Shimojo et al.
HYPERTENSION (2015)
A new predictor of mortality in hemodialysis patients; Tenascin-C
Sukru Ulusoy et al.
LIFE SCIENCES (2015)
CCN1 suppresses pulmonary vascular smooth muscle contraction in response to hypoxia
Seon-jin Lee et al.
PULMONARY CIRCULATION (2015)
Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure
Alexander E. Berezin et al.
BIOMEDICAL JOURNAL (2015)
Prognostic utility of serum vitronectin levels in acute myocardial infarction
S. Aslan et al.
HERZ (2015)
Matrix Metalloproteinases are Involved in Cardiovascular Diseases
Aline Azevedo et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Fibrosis Marker Syndecan-1 and Outcome in Patients With Heart Failure With Reduced and Preserved Ejection Fraction
Jasper Tromp et al.
CIRCULATION-HEART FAILURE (2014)
Vitronectin levels and coronary artery disease severity in acute coronary syndromes
S. Aslan et al.
EUROPEAN HEART JOURNAL (2014)
Serum tenascin-C level is associated with coronary plaque rupture in patients with acute coronary syndrome
Nobuo Sakamoto et al.
HEART AND VESSELS (2014)
Connective Tissue Growth Factor Inhibition Attenuates Left Ventricular Remodeling and Dysfunction in Pressure Overload-Induced Heart Failure
Zoltan Szabo et al.
HYPERTENSION (2014)
Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts
Sheng Zhao et al.
JOURNAL OF CARDIOLOGY (2014)
Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts
Jianyong Zhong et al.
LABORATORY INVESTIGATION (2014)
Cardioprotective Effects of Osteopontin-1 during Development of Murine Ischemic Cardiomyopathy
Georg D. Duerr et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Tenascin-C Aggravates Autoimmune Myocarditis via Dendritic Cell Activation and Th17 Cell Differentiation
Tomoko Machino-Ohtsuka et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Thrombospondins, Potential Drug Targets for Cardiovascular Diseases
Erja Mustonen et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2013)
Thrombospondins: old players, new games
Olga Stenina-Adognravi
CURRENT OPINION IN LIPIDOLOGY (2013)
Innate immune signaling induces expression and shedding of the heparan sulfate proteoglycan syndecan-4 in cardiac fibroblasts and myocytes, affecting inflammation in the pressure-overloaded heart
Mari E. Strand et al.
FEBS JOURNAL (2013)
CCN2/CTGF attenuates myocardial hypertrophy and cardiac dysfunction upon chronic pressure-overload
Jorgen Gravning et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Stimulating Myocardial Regeneration with Periostin Peptide in Large Mammals Improves Function Post-Myocardial Infarction but Increases Myocardial Fibrosis
Dennis Ladage et al.
PLOS ONE (2013)
Cysteine-rich protein 61 (CCN1) and connective tissue growth factor (CCN2) at the crosshairs of ocular neovascular and fibrovascular disease therapy
Lulu Yan et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2013)
Time course of right ventricular pressure-overload induced myocardial fibrosis: relationship to changes in fibroblast postsynthetic procollagen processing
Catalin F. Baicu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells
Anna-Pia Papageorgiou et al.
CARDIOVASCULAR RESEARCH (2012)
Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1
Philip M. Bauer et al.
CARDIOVASCULAR RESEARCH (2012)
Thrombospondin-4 regulates fibrosis and remodeling of the myocardium in response to pressure overload
Ella G. Frolova et al.
FASEB JOURNAL (2012)
Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction
Jun Xie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Increased level of soluble syndecan-1 in serum correlates with myocardial expression in a rat model of myocardial infarction
Juan Lei et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Myocardial Connective Tissue Growth Factor (CCN2/CTGF) Attenuates Left Ventricular Remodeling after Myocardial Infarction
Jorgen Gravning et al.
PLOS ONE (2012)
Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury
M. Shakil Ahmed et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
SPARC mediates early extracellular matrix remodeling following myocardial infarction
Sarah M. McCurdy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Extracellular Matrix and Heart Development
Marie Lockhart et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2011)
Blood Level of Osteonectin in Stenosing Atherosclerosis and Calcinosis of Coronary Arteries
Yu. I. Ragino et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Syndecan-4 Prevents Cardiac Rupture and Dysfunction After Myocardial Infarction
Yutaka Matsui et al.
CIRCULATION RESEARCH (2011)
Osteopontin plasma levels and accelerated atherosclerosis in patients with CAD undergoing PCI: a prospective clinical study
Annamaria Mazzone et al.
CORONARY ARTERY DISEASE (2011)
Endogenous Thrombospondin 1 Protects the Pressure-Overloaded Myocardium by Modulating Fibroblast Phenotype and Matrix Metabolism
Ying Xia et al.
HYPERTENSION (2011)
Fibrosis and Cardiac Arrhythmias
Sanne de Jong et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Identification of a Sequence in the Matricellular Protein SPARC That Interacts With the Scavenger Receptor Stabilin-1
Gail Workman et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Syndecan-4 Is Essential for Development of Concentric Myocardial Hypertrophy via Stretch-Induced Activation of the Calcineurin-NFAT Pathway
Alexandra V. Finsen et al.
PLOS ONE (2011)
The Thrombospondins
Josephine C. Adams et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Angiotensin II receptor blocker and statins lower elevated levels of osteopontin in essential hypertension-Results from the EUTOPIA trial
Johan M. Lorenzen et al.
ATHEROSCLEROSIS (2010)
Periostin mediates vascular smooth muscle cell migration through the integrins ανβ3 and ανβ5 and focal adhesion kinase (FAK) pathway
Guohong Li et al.
ATHEROSCLEROSIS (2010)
Matricellular Signaling Molecule CCN1 Attenuates Experimental Autoimmune Myocarditis by Acting as a Novel Immune Cell Migration Modulator
Madlen Rother et al.
CIRCULATION (2010)
Human Adult Vena Saphena Contains Perivascular Progenitor Cells Endowed With Clonogenic and Proangiogenic Potential
Paola Campagnolo et al.
CIRCULATION (2010)
Syndecan-1 Amplifies Angiotensin II-Induced Cardiac Fibrosis
Mark W. M. Schellings et al.
HYPERTENSION (2010)
Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents
Daihiko Hakuno et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Plasma Osteopontin as a Predictor of Coronary Artery Disease: Association With Echocardiographic Characteristics of Atherosclerosis
Hala Abdel-Hameed Abdel-Azeez et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2010)
Periostin Is a Novel Factor in Cardiac Remodeling After Experimental and Clinical Unloading of the Failing Heart
William E. Stansfield et al.
ANNALS OF THORACIC SURGERY (2009)
Absence of Thrombospondin-2 Causes Age-Related Dilated Cardiomyopathy
Melissa Swinnen et al.
CIRCULATION (2009)
Pressure Overload-Induced Alterations in Fibrillar Collagen Content and Myocardial Diastolic Function Role of Secreted Protein Acidic and Rich in Cysteine (SPARC) in Post-Synthetic Procollagen Processing
Amy D. Bradshaw et al.
CIRCULATION (2009)
Vitronectin Concentrations Predict Risk in Patients Undergoing Coronary Stenting
Wolfgang Derer et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2009)
Endothelin-1 induces connective tissue growth factor expression in cardiomyocytes
Anna Grazia Recchia et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Transcriptional changes in right ventricular tissues are enriched in the outflow tract compared with the apex during chronic pulmonary embolism in rats
John Zagorski et al.
PHYSIOLOGICAL GENOMICS (2009)
The role of osteopontin in inflammatory processes
Susan Amanda Lund et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
The role of SPARC in extracellular matrix assembly
Amy D. Bradshaw
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2009)
CCN1 knockdown suppresses neointimal hyperplasia in a rat artery balloon injury model
Hironobu Matsumae et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Thrombospondin-4 expression is rapidly upregulated by cardiac overload
Erja Mustonen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Heparan Sulfate in Perlecan Promotes Mouse Atherosclerosis
Karin Tran-Lundmark et al.
CIRCULATION RESEARCH (2008)
Periostin is required for maturation and extracellular matrix stabilization of noncardiomyocyte lineages of the heart
Paige Snider et al.
CIRCULATION RESEARCH (2008)
Transgenic expression of matrix metalloproteinase-1 inhibits myocardial fibrosis and prevents the transition to heart failure in a pressure overload mouse model
Robert F. Foronjy et al.
HYPERTENSION RESEARCH (2008)
Periostin is essential for cardiac healing after acute myocardial infarction
Masashi Shimazaki et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Circulating levels of osteopontin, osteoprotegerin, total soluble receptor activator of nuclear factor-kappa B ligand, and high-sensitivity C-reactive protein in patients with active rheumatoid arthritis randomized to etanercept alone or in combination with methotrexate
H. P. Sennels et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2008)
Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function
Francis G. Spinale
PHYSIOLOGICAL REVIEWS (2007)
Reverse ventricular remodelling after cardiac resynchronization therapy is associated with a reduction in serum tenascin-C and plasma matrix metalloproteinase-9 levels
Marleen H. M. Hessel et al.
EUROPEAN JOURNAL OF HEART FAILURE (2007)
Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling
Toru Oka et al.
CIRCULATION RESEARCH (2007)
Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer
Andrew Lindsley et al.
DEVELOPMENTAL BIOLOGY (2007)
Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: Involvement of tenascin-C induced by aldosterone-mediated inflammation
Tomohiro Nishioka et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Reduced perlecan expression and accumulation in human carotid atherosclerotic lesions
Phan-Kiet Tran et al.
ATHEROSCLEROSIS (2007)
Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction
Davy Vanhoutte et al.
CIRCULATION (2007)
The regulation and role of osteopontin in malignant transformation and cancer
Mohamed K. El-Tanani et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
BRCA1 suppresses osteopontin-mediated breast cancer
Mohamed K. El-Tanani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Thrombospondin-4 1186G>C (A387P) is a sex-dependent risk factor for myocardial infarction:: A large replication study with increased sample size from the same population
Jianxun Cui et al.
AMERICAN HEART JOURNAL (2006)
Transduction of a mesenchyme-specific gene periostin into 293T cells induces cell invasive activity through epithelial-mesenchymal transformation
Wei Yan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Serum tenascin-C might be a novel predictor of left ventricular remodeling and prognosis after acute myocardial infarction
Akira Sato et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload
H Matsusaka et al.
HYPERTENSION (2006)
Structure and function of matrix metalloproteinases and TIMPs
H Nagase et al.
CARDIOVASCULAR RESEARCH (2006)
Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration
S Pullamsetti et al.
RESPIRATORY RESEARCH (2005)
Enhanced expression of fibrillin-1, a constituent of the myocardial extracellular matrix in fibrosis
F Bouzeghrane et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts
NG Frangogiannis et al.
CIRCULATION (2005)
Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension
H Lepetit et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Plasma osteopontin levels in multiple sclerosis
M Comabella et al.
JOURNAL OF NEUROIMMUNOLOGY (2005)
Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway
SD Bao et al.
CANCER CELL (2004)
Connective-tissue growth factor - a novel mediator of angiotensin II-stimulated cardiac fibroblast activation in heart failure in rats
MS Ahmed et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Increased syndecan expression following myocardial infarction indicates a role in cardiac remodeling
AV Finsen et al.
PHYSIOLOGICAL GENOMICS (2004)
Thrombospondin-2 is essential for myocardial matrix integrity - Increased expression identifies failure-prone cardiac hypertrophy
B Schroen et al.
CIRCULATION RESEARCH (2004)
Angiotensin II signals mechanical stretch-induced cardiac matrix metalloproteinase expression via JAK-STAT pathway
TL Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2004)
Plasma MMP-9 and MMP-2 following acute myocardial infarction in man: Correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction
IB Squire et al.
JOURNAL OF CARDIAC FAILURE (2004)
Osteopontin modulates myocardial hypertrophy in response to chronic pressure overload in mice
ZL Xie et al.
HYPERTENSION (2004)
Endothelin-1 regulates protein kinase C isoforms differently in smooth muscle cells and in cardiomyocytes
SC Wolf et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Connective tissue growth factor expression and Smad signaling during mouse heart development and myocardial infarction
SMCDS Lopes et al.
DEVELOPMENTAL DYNAMICS (2004)
Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II - Induced cardiac hypertrophy
Y Matsui et al.
HYPERTENSION (2004)
Regulation of proangiogenic factor CCN1 in cardiac muscle - Impact of ischemia, pressure overload, and neurohumoral activation
D Hilfiker-Kleiner et al.
CIRCULATION (2004)
Matricellular proteins in the heart: possible role during stress and remodeling
MWM Schellings et al.
CARDIOVASCULAR RESEARCH (2004)
Osteopontin modulates angiotensin II-induced fibrosis in the intact murine heart
AR Collins et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Replication of the association between the thrombospondin-4 A387P polymorphism and myocardial infarction
J Wessel et al.
AMERICAN HEART JOURNAL (2004)
Angiogenic activity of osteopontin-derived peptide SVVYGLR
Y Hamada et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Selective targeting and timing of matrix metalloproteinase inhibition in post-myocardial infarction remodeling
WM Yarbrough et al.
CIRCULATION (2003)
Spatially and temporally different expression of osteonectin and osteopontin in the infarct zone of experimentally induced myocardial infarction in rats
I Komatsubara et al.
CARDIOVASCULAR PATHOLOGY (2003)
SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength
AD Bradshaw et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development
S Ivkovic et al.
DEVELOPMENT (2003)
Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease
S Blankenberg et al.
CIRCULATION (2003)
Matrix metalloproteinase inhibition modifies left ventricular remodeling after myocardial infarction in pigs
WM Yarbrough et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2003)
Myocardial infarct expansion and matrix metalloproteinase inhibition
R Mukherjee et al.
CIRCULATION (2003)
Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction
SM Boekholdt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
CYR61 (CCN1) is essential for placental development and vascular integrity
FE Mo et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Early onset of chondroitin sulfate and osteopontin expression in angiotensin II-dependent left ventricular hypertrophy
L Rothermund et al.
AMERICAN JOURNAL OF HYPERTENSION (2002)
Tenascin-C is a useful marker for disease activity in myocarditis
K Imanaka-Yoshida et al.
JOURNAL OF PATHOLOGY (2002)
Effects of matrix metalloproteinase inhibition on ventricular remodeling due to volume overload
AL Chancey et al.
CIRCULATION (2002)
Osteopontin - a molecule for all seasons
M Mazzali et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2002)
Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis
VV Kunjathoor et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Immunohistochemical study of endothelin-1 and matrix metalloproteinases in plexogenic pulmonary arteriopathy
K Matsui et al.
PATHOLOGY RESEARCH AND PRACTICE (2002)
Single nucleotide polymorphisms in multiple novel thrombospondin genes may be associated with familial premature myocardial infarction
EJ Topol et al.
CIRCULATION (2001)
Matrix metalloproteinase expression and activity in isolated myocytes after neurohormonal stimulation
ML Coker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
The expression of SPARC in adipose tissue and its increased plasma concentration in patients with coronary artery disease
M Takahashi et al.
OBESITY RESEARCH (2001)
Tenascin-C modulates adhesion of cardiomyocytes to extracellular matrix during tissue remodeling after myocardial infarction
K Imanaka-Yoshida et al.
LABORATORY INVESTIGATION (2001)
Effect of coronary thrombolysis on the plasma concentration of osteonectin (SPARC, BM40) in patients with acute myocardial infarction
VL Serebruany et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2000)
Angiotensin II induces nuclear factor-κB activation in cultured neonatal rat cardiomyocytes through protein kinase C signaling pathway
P Rouet-Benzineb et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Expression of perlecan proteoglycan in the infarct zone of mouse myocardial infarction
M Nakahama et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
